Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation

Cited by (276)

Items 101–200 of 276

1. Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk
   Harpreet Singh Bhatia, Jonathan Chong Hsu, Robert J. Kim · 2018 · Clinical Cardiology
2. Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
   Gürbey Ocak, Marlies Noordzij, Maarten B. Rookmaaker, Aleix Cases, Cécile Couchoud, James Goya Heaf, Faiçal Jarraya, Johan De Meester, Jaap W. Groothoff, Bård Endre Waldum-Grevbo et al. · 2018 · Journal of Thrombosis and Haemostasis
3. Comparison of novel oral anticoagulants versus vitamin K antagonists in patients with chronic kidney disease
   Ziv Harel, Manish M. Sood, Jeffrey M. Perl · 2015 · Current Opinion in Nephrology & Hypertension
4. Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis
   Meng Lee, Jeffrey L. Saver, Keun‐Sik Hong, Yi‐Ling Wu, Wen-Hong Huang, Neal Matsumori Rao, Bruce I Ovbiagele · 2016 · Medicine
5. Direct Oral Anticoagulants in End-Stage Renal Disease
   Vicky Tagalakis, Adi Joseph Klil-Drori · 2018 · Seminars in Thrombosis and Hemostasis
6. Vitamin K Antagonists: Beyond Bleeding
   Thilo Krüger, Jürgen Floege · 2014 · Seminars in Dialysis
7. Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study
   Diego Brancaccio, Luca Neri, Francesco Bellocchio, Carlo Barbieri, Claudia Amato, Flavio Mari, Bernard Canaud, Stefano Stuard · 2016 · American Journal of Nephrology
8. Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI)
   Oliver Königsbrügge, Matthias Lorenz, Martin Auinger, Sabine Schmaldienst, Renate Klauser‐Braun, Josef Kletzmayr, Ella Grilz, Florian Posch, Marlies Antlanger, Ingrid Pabinger et al. · 2017 · Thrombosis Research
9. Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries
   Anders Nissen Bonde, Gregory Y.H. Lip, Anne‐Lise Kamper, Laila Stærk, Christian Tobias Torp-Pedersen, Gunnar Gislason, Jonas Bjerring Olesen · 2017 · Thrombosis and Haemostasis
10. Atrial fibrillation and chronic kidney disease requiring hemodialysis — Does warfarin therapy improve the risks of this lethal combination?
    Lohit Garg, Charity Chen, David E. Haines · 2016 · International Journal of Cardiology
11. Clinical Outcomes of Warfarin Initiation in Advanced Chronic Kidney Disease Patients With Incident Atrial Fibrillation
    Manyoo A. Agarwal, Praveen Kumar Potukuchi, Keiichi Sumida, Adnan Naseer, Miklos Zsolt Molnar, Lekha K. George, Santhosh K. G. Koshy, Elani Streja, Fridtjof Thomas, Kamyar Kalantar‐Zadeh et al. · 2020 · JACC. Clinical electrophysiology
12. Ischemic and Hemorrhagic Stroke: High Incidence in Hemodialysis and Peritoneal Dialysis Patients
    David A. Drew, Mark J. Sarnak · 2014 · American Journal of Kidney Diseases
13. The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Shmuel Schwartzenberg, Eli Israel Lev, Alexander Sagie, Asher Korzets, Ran Kornowski · 2015 · The American Journal of Cardiology
14. Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease
    Yanan Wang, Yi Yang, Fan He · 2022 · Reviews in Cardiovascular Medicine
15. Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation
    Amber O. Molnar, Manish M. Sood · 2017 · Seminars in Dialysis
16. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage
    Nicole Louise De La Mata, Maria Alfaro-Ramirez, Patrick John Kelly, Philip Masson, Rustam Al‐Shahi Salman, Angela Claire Webster · 2019 · BMJ Open
17. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk
    Maximilian Brockmeyer, Georg Wolff, Torben Krieger, Yingfeng Lin, Athanasios Karathanos, Shazia Afzal, Tobias Zeus, Ralf Westenfeld, Amin Polzin, Yvonne Heinen et al. · 2019 · Acta cardiologica. Supplementum
18. Renal replacement modality and stroke risk in end-stage renal disease—a national registry study
    Mark Findlay, Rachael L. Macisaac, Mary Joan MacLeod, Wendy Metcalfe, Jamie P. Traynor, Jesse Dawson, Patrick Barry Mark · 2017 · Nephrology Dialysis Transplantation
19. Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation
    Colin R. Lenihan, Maria E. Montez‐Rath, Jenny I. Shen, John D. Scandling, Mintu P. Turakhia, Tara I. Chang, Wolfgang C. Winkelmayer­ · 2014 · Nephrology Dialysis Transplantation
20. Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Sohil Elfar, Sara Mohamed Elzeiny, Hesham Ismail, Yahya Makkeyah, Mokhtar N. Ibrahim · 2022 · Frontiers in Cardiovascular Medicine
21. Antikoagulation bei Patienten mit chronischer Niereninsuffizienz
    Georg Schlieper, Vedat Schwenger, Andrew B Remppis, Till Keller, Ralf Dechend, Steffen Maßberg, Stephan Ernst Baldus, Thomas Weinreich, Gerd Ruediger Hetzel, Jürgen Floege et al. · 2017 · Der Internist
22. Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Martin van Zyl, Hafez Mohammad Ammar Abdullah, Peter A. Noseworthy, Konstantinos C. Siontis · 2020 · Journal of Clinical Medicine
23. Vitamin K antagonist use and mortality in dialysis patients
    Pauline W. M. Voskamp, Maarten B. Rookmaaker, Marianne Christina Verhaar, Friedo Wilhelm Dekker, Gürbey Ocak · 2017 · Nephrology Dialysis Transplantation
24. Atrial fibrillation in chronic kidney disease
    Luminita E. Voroneanu, Alberto Ortíz, Ionuţ Nistor, Adrian Constantin Covic · 2016 · European Journal of Internal Medicine
25. Association of warfarin with congestive heart failure and peripheral artery occlusive disease in hemodialysis patients with atrial fibrillation
    Kuo‐Hua Lee, Szu‐Yuan Li, Jin-Sin Liu, Chi-Ting Huang, Ying-Ying Chen, Yao‐Ping Lin, Chih-Cheng Hsu, Der‐Cherng Tarng · 2017 · Journal of the Chinese Medical Association
26. Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.
    Yazan S. Khouri, Tiona Stephens, Gloria A. Ayuba, Hazim Al‐Ameri, Nour Juratli, Peter Andrew McCullough · 2015 · Europe PMC (PubMed Central)
27. Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Eric Black‐Maier, Jonathan Paul Piccini · 2017 · Heart
28. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Marin Nishimura, Jonathan Chong Hsu · 2017 · The American Journal of Cardiology
29. Stroke Prevention in Atrial Fibrillation
    Chern‐En Chiang, Tze‐Fan Chao, Eue‐Keun Choi, Toon Wei Lim, Rungroj Krittayaphong, Mingfang Li, Minglong Chen, Yutao Guo, Ken Okumura, Gregory Y.H. Lip · 2022 · JACC Asia
30. Individualized approaches to thromboprophylaxis in atrial fibrillation
    Oliver Jonathan Ziff, A. John Camm · 2015 · American Heart Journal
31. Nuevos anticoagulantes orales en pacientes con enfermedad renal crónica
    Lara Belmar, Ángel L.M. de Francisco, Jairo Bada da Silva, Luis Galván Espinoza, Gema Fernández Fresnedo · 2016 · Nefrología
32. Improving outcomes by changing hemodialysis practice patterns
    Rachel B. Fissell, Raymond M. Hakim · 2013 · Current Opinion in Nephrology & Hypertension
33. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation
    Eric Black‐Maier, Jonathan Paul Piccini, Christopher Bull Granger · 2019 · Journal of Cardiovascular Electrophysiology
34. A Pint of Sweat Will Save a Gallon of Blood
    Christopher Bull Granger, Glenn Matthew Chertow · 2014 · Circulation
35. Is anticoagulating haemodialysis patients with non‐valvular atrial fibrillation too risky?
    Kathrine Parker, Sandip Mitra, Jecko V. Thachil · 2018 · British Journal of Haematology
36. Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
    Hanjin Park, Hee Tae Yu, Tae‐Hoon Kim, Jin‐Kyu Park, Jin‐Kyu Park, Ki‐Woon Kang, Jae‐Sun Uhm, Jun Kim, Jun Kim, Eue‐Keun Choi et al. · 2022 · Yonsei Medical Journal
37. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry
    Yugo Yamashita, Daisuke Takagi, Yasuhiro Hamatani, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Yeong‐Hwa Chun, Hitoshi Itoh, Masato Nishimura, Hiromichi Wada et al. · 2016 · Heart and Vessels
38. Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis
    Derek Q. Phan, Su-Jau Yang, Albert Yuh‐Jer Shen, Mingsum S Lee · 2019 · American Journal of Cardiovascular Drugs
39. Effect of impaired renal function on the maintenance dose of warfarin in Japanese patients
    Nao Ichihara, Tomoaki Ishigami, Satoshi Umemura · 2014 · Journal of Cardiology
40. Stroke Prevention in Patients With Atrial Fibrillation and Renal Dysfunction
    Scott S. Kaatz, Charles Edward Mahan · 2014 · Stroke
41. Efficacy and safety of novel anticoagulants versus vitamin K antagonists in patients with mild and moderate to severe renal insufficiency: Focus on apixaban
    Francesco Pelliccia, Salvatore Rosanio, Giuseppe Marazzi, Sara Poggi, Alessandra Tanzilli, Cesare Greco, Carlo Gaudio, Giuseppe M.C. Rosano · 2016 · International Journal of Cardiology
42. The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation
    Simonetta Genovesi, Emanuela Rossi, Daniela Pogliani, Maurizio Alberto Gallieni, Andréa Stella, Fabio Badiali, Ferruccio Conte, Sonia Pasquali, Silvio Volmer Bertoli, Patrizia Ondei et al. · 2014 · Journal of Nephrology
43. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study
    the Warfarin Study Group, Matsuhiko Hayashi, Takayuki Abe, Mieko Iwai, Ayumi Matsui, Tadashi Yoshida, Yuji Sato, Yoshihiko Kanno · 2015 · Clinical and Experimental Nephrology
44. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis
    Solène M. Laville, Cécile Couchoud, Marc Bauwens, Henri Vacher-Coponat, Gabriel J. Choukroun, Sophie Liabeuf, for the REIN Collaborators, Nadia Honoré, Sabrina Boime, Emilie Gardeur-Algros et al. · 2024 · Nephrology Dialysis Transplantation
45. Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes
    Chieh Tsai, Laura Quinn Marcus, Priya Patel, Marisa Battistella · 2017 · Canadian Journal of Kidney Health and Disease
46. Renal Disease and Atrial Fibrillation
    Maria Stefil, Katarzyna Nabrdalik, Gregory Y.H. Lip · 2021 · Cardiac Electrophysiology Clinics
47. Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse
    Nikolaos Ktenopoulos, Μarios Sagris, Panagiotis Theofilis, Sophia Lionaki, Lοukianos S. Rallidis · 2022 · Frontiers in Bioscience-Scholar
48. Acute Stroke Thrombolysis in End-Stage Renal Disease: A National Survey of Nephrologist Opinion
    Albert John Power, Damian G. Fogarty, David Collins. Wheeler · 2013 · Nephron Clinical Practice
49. Changing the hemodialysis prescription for hemodialysis patients with subdural and intracranial hemorrhage
    Andrew Davenport · 2013 · Hemodialysis International
50. Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
    Ting‐Tse Lin, Jiun‐Yang Chiang, Min‐Tsun Liao, Chia‐Ti Tsai, Juey‐Jen Hwang, Fu‐Tien Chiang, Jiunn-Lee Lin, Lian‐Yu Lin · 2015 · Scientific Reports
51. Preoperative Cardiovascular Assessment of the Renal Transplant Recipient: A Narrative Review
    Prasanti Alekhya Kotta, Madhivanan Elango, Vassilios E Papalois · 2021 · Journal of Clinical Medicine
52. Anticoagulation in Patients With Advanced Chronic Kidney Disease: Walking the Fine Line Between Benefit and Harm
    Januvi Jegatheswaran, Gregory L. Hundemer, David Massicotte‐Azarniouch, Manish M. Sood · 2019 · Canadian Journal of Cardiology
53. Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review
    Heitor Martins de Oliveira, Lorrany Pereira Barros, Maria Clara Azzi Vaz de Campos, Rafael Ferreira Daher, Gil Batista Gonçalves, Mateus Teodoro Sequeira, Silvia Marçal Botelho, Antônio da Silva Menezes · 2025 · Reviews in Cardiovascular Medicine
54. 2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
    Jung‐Myung Lee, Boyoung Joung, Myung‐Jin Cha, Ji Hyun Lee, Woo‐Hyun Lim, Tae‐Hoon Kim, Seung Yong Shin, Jae‐Sun Uhm, Hong Euy Lim, Jin‐Bae Kim et al. · 2018 · Korean Journal of Medicine
55. Warfarin Usage in Patients With Atrial Fibrillation Undergoing Hemodialysis in Indonesian Population
    Mohammad Rizki Akbar, Mega Febrianora, Mohammad Iqbal · 2022 · Current Problems in Cardiology
56. Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Kenneth Scott Brimble, Alistair John Ingram, John W. Eikelboom, Robert G. Hart · 2012 · Postgraduate Medicine
57. Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation
    Wenfeng He, Hao Zhang, Wengen Zhu, Zhengbiao Xue · 2019 · Medicine
58. Warfarin accelerated vascular calcification and worsened cardiac dysfunction in remnant kidney mice
    Ming‐Tsun Tsai, Yingying Chen, Wei-Jeng Chang, Szu‐Yuan Li · 2018 · Journal of the Chinese Medical Association
59. Antithrombotic medications in dialysis patients: a double‐edged sword
    Georgios Vlachopanos, Farid Girgis Ghalli · 2016 · Journal of Evidence-Based Medicine
60. Antithrombotic therapy in end‐stage renal disease
    Svetha Chunduri, Jon E. Folstad, Tushar J. Vachharajani · 2017 · Hemodialysis International
61. Impacto pronóstico a largo plazo de la anticoagulación en pacientes en hemodiálisis con fibrilación auricular
    Ruth María Sánchez Soriano, María Dolores Albero Molina, Carlos Israel Chamorro Fernández, Rocío Juliá‐Sanchis, Ramón López-Menchero, Carlos del Pozo Fernández, Guillermo Grau Jornet, Julio Núñez Villota · 2018 · Nefrología
62. Warfarin and the Risk of Death, Stroke, and Major Bleeding in Patients With Atrial Fibrillation Receiving Hemodialysis: A Systematic Review and Meta-Analysis
    Hong Lei, Liting Yu, Weining Wang, Shunguo Zhang · 2018 · Frontiers in Pharmacology
63. Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.
    Nobuhiro Nakanishi, Koichi Kaikita, Masanobu Ishii, Naoto Kuyama, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Tadashi Hoshiyama, Hisanori Kanazawa et al. · 2021 · Thrombosis Research
64. Atrial fibrillation and chronic kidney disease: struggling through thick and thin
    Simardeep Gill, Min Jun, Pietro Ravani · 2016 · Nephrology Dialysis Transplantation
65. Observational Research Using Propensity Scores
    Karthik Raghunathan, J. Bradley Layton, Tetsu Ohnuma, Andrew Shaw · 2016 · Advances in Chronic Kidney Disease
66. New oral anticoagulants in patients with chronic kidney disease
    Lara Belmar, Ángel L.M. de Francisco, Jairo Bada da Silva, Luis Galván Espinoza, Gema Fernández Fresnedo · 2017 · Nefrología (English Edition)
67. Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)
    Mohit Madken, Ranjeeta Mallick, Emily Rhodes, Roshanak Mahdavi, Anan Bader Eddeen, Gregory L. Hundemer, Dearbhla Kelly, Angelo Karaboyas, Bruce M. Robinson, Brian A. Bieber et al. · 2023 · Canadian Journal of Kidney Health and Disease
68. Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease
    Jingwen Tan, Sunjae Bae, Jodi B Segal, Junya Zhu, Dorry Lidor Segev, G. Caleb Alexander, Mara McAdams‐DeMarco · 2017 · Journal of Nephrology
69. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients
    Jenny I. Shen, Maria E. Montez‐Rath, Aya Mitani, Kevin F. Erickson, Wolfgang C. Winkelmayer­ · 2014 · Pharmacoepidemiology and Drug Safety
70. Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease
    Carmine Zoccali, Francesca Mallamaci · 2012 · Journal of Thrombosis and Haemostasis
71. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review
    Sara L. Wing, Thomas A. Mavrakanas, Ziv Harel · 2024 · Seminars in Nephrology
72. Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients
    Yao Du, Yuwen Zeng, Sixin Xu, Qiwei Shen, Jinzhu Hu, Gregory Y.H. Lip · 2025 · European Journal of Clinical Investigation
73. 2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
    Jung‐Myung Lee, Boyoung Joung, Myung‐Jin Cha, Ji Hyun Lee, Woo‐Hyun Lim, Tae‐Hoon Kim, Seung Yong Shin, Jae‐Sun Uhm, Hong Euy Lim, Jin‐Bae Kim et al. · 2018 · Korean Journal of Medicine
74. Anticoagulant for treatment and prophylaxis of venous thromboembolism patients with renal dysfunction: A systematic review and network meta-analysis
    Guohui Fan, Dingyi Wang, Meng Zhang, Xufei Luo, Zhenguo Zhai, Sinan Wu · 2022 · Frontiers in Medicine
75. Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease
    Ellen Linnea Freese Ballegaard, Jonas Bjerring Olesen, Anne‐Lise Kamper, Bo Feldt‐Rasmussen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Nicholas Carlson · 2024 · Research and Practice in Thrombosis and Haemostasis
76. Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
    Nisha Bansal · 2016 · Clinical Journal of the American Society of Nephrology
77. Anti‐thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views
    Rugheed Ghadban, Greg Flaker, Natraj Katta, Martin Alpert · 2017 · Hemodialysis International
78. Renal Function and Oral Anticoagulant Treatment of Incident non-valvular Atrial Fibrillation: A Retrospective Study
    Sreeram V Ramagopalan, Elaine Stamp, Cormac Sammon, Megan Besford, Robert Carroll, Faisal Mehmud, Raza Alikhan · 2019 · Future Cardiology
79. The use of non‐vitamin K oral anticoagulants in dialysis patients—A systematic review
    Agitha Chandrasegaram, Christian Daugaard Peters · 2022 · Seminars in Dialysis
80. 2018 KHRS Expert Consensus Recommendation for Oral Anticoagulants Choice and Appropriate Doses: Specific Situation and High Risk Patients
    Ki Hong Lee, Boyoung Joung, So‐Ryoung Lee, You Mi Hwang, Junbeom Park, Yong‐Soo Baek, Yae Min Park, Jin‐Kyu Park, Hwan Cheol Park, Hyung Wook Park et al. · 2018 · Korean Journal of Medicine
81. Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis
    Xianfeng Shen, Chao Zhang, Jun Hu, Tao Zhang, Bin Ma · 2023 · Frontiers in Pharmacology
82. Can cardiovascular risk in dialysis patients be decreased?
    Peter Stenvinkel, Peter F. Barany · 2011 · Nature Reviews Nephrology
83. Pretransplant risk stratification for early survival of renal allograft recipients
    Željko Kikić, Harald Herkner, Gürkan Sengölge, Nicolas Kozakowski, Gregor Bond, Max Plischke · 2013 · European Journal of Clinical Investigation
84. Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.
    Tze‐Fan Chao, Shih‐Ann Chen · 2015 · PubMed Central
85. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Harpreet Singh Bhatia, Joseph Bailey, Ozan Ünlü, Katherine Hoffman, Robert J. Kim · 2019 · Pacing and Clinical Electrophysiology
86. Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease
    Tania Ahuja, Kelly Sessa, Cristian Merchan, John Papadopoulos, David Green · 2021 · Advances in Hematology
87. Prediction of cardiovascular outcome by estimated glomerular filtration rate among high-risk patients: a Thai nationwide cohort study
    Noppawit Aiumtrakul, Annop Kittithaworn, Ouppatham Supasyndh, Rungroj Krittayaphong, Arintaya Phrommintikul, Bancha Satirapoj · 2022 · Clinical and Experimental Nephrology
88. Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation
    Min Soo Cho, Hyung Oh Choi, Ki Won Hwang, Jun Kim, Gi‐Byoung Nam, Kee‐Joon Choi · 2023 · BMC Cardiovascular Disorders
89. Still unresolved: warfarin in ESRD with atrial fibrillation
    Wolfgang C. Winkelmayer­ · 2014 · Nature Reviews Nephrology
90. Ischemic Stroke among the Patients with End-Stage Renal Disease Who Were Undergoing Maintenance Dialysis
    San Jung, Seok-Beom Kwon, Sung‐Hee Hwang, Jung‐Woo Noh, Young‐Ki Lee · 2012 · Yonsei Medical Journal
91. Atrial Fibrillation in Dialysis Patients: Time to Abandon Warfarin?
    Diego Brancaccio, Luca Neri, Francesco Bellocchio, Carlo Barbieri, Claudia Amato, Flavio Mari, Bernard Canaud, Stefano Stuard · 2016 · The International Journal of Artificial Organs
92. Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses
    Mustafa Kılıçkap, Jackie Bosch, John W. Eikelboom, Robert G. Hart · 2016 · Canadian Journal of Cardiology
93. Medical safety in the care of the person with end‐stage kidney disease
    John V. Duronville, Clarissa Jonas Diamantidis · 2018 · Seminars in Dialysis
94. Vitamin K antagonist use and renal function in pre-dialysis patients
    Pauline W. M. Voskamp, Friedo Wilhelm Dekker, Maarten B. Rookmaaker, Marianne Christina Verhaar, Willem Jan W. Bos, Merel van Diepen, Gürbey Ocak · 2018 · Clinical Epidemiology
95. Atrial Fibrillation and Chronic Kidney Disease
    Georg Schlieper, Thilo Krüger, Jürgen Floege · 2012 · New England Journal of Medicine
96. L’éveil de la matrix-gla-protéine sonnera le glas des calcifications vasculaires
    Pierre Delanaye, Sophie Liabeuf, Antoine Bouquegneau, Etienne Cavalier, Ziad A. Massy · 2015 · Néphrologie & Thérapeutique
97. A case of a severe factor XI deficiency in patient undergoing hemodialysis without the use of heparin
    Yasuyuki Takamizawa, Makoto Araki, Noriko Yoshida, Teruaki Yoshioka, Kohei Miura · 2014 · Blood Coagulation & Fibrinolysis
98. Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is It Time to Abandon It?
    Marek Saracyn, Dorota Anna Brodowska-Kania, Stanisław Niemczyk · 2013 · The Scientific World JOURNAL
99. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin
    Yee Cheng Lau, Qinmei Xiong, Gregory Y.H. Lip, Andrew D. Blann · 2016 · Annals of Medicine
100. Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?
     Sánchez González, José Antonio Herrero Calvo · 2022 · Nefrología